康臣药业(01681)11月11日耗资约296.92万港元回购20万股

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating a strategic move to enhance shareholder value through the repurchase of shares [1] Summary by Category Company Actions - 康臣药业 plans to repurchase 200,000 shares at a cost of approximately HKD 2.9692 million on November 11, 2025 [1]